ATE295157T1 - Mittel zur transdermalen verabreichung von arzneistoffen - Google Patents
Mittel zur transdermalen verabreichung von arzneistoffenInfo
- Publication number
- ATE295157T1 ATE295157T1 AT97901642T AT97901642T ATE295157T1 AT E295157 T1 ATE295157 T1 AT E295157T1 AT 97901642 T AT97901642 T AT 97901642T AT 97901642 T AT97901642 T AT 97901642T AT E295157 T1 ATE295157 T1 AT E295157T1
- Authority
- AT
- Austria
- Prior art keywords
- medicinal
- agent
- drug
- transdermal administration
- medicine
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
- A61K47/51—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
- A61K47/56—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic macromolecular compound, e.g. an oligomeric, polymeric or dendrimeric molecule
- A61K47/58—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic macromolecular compound, e.g. an oligomeric, polymeric or dendrimeric molecule obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. poly[meth]acrylate, polyacrylamide, polystyrene, polyvinylpyrrolidone, polyvinylalcohol or polystyrene sulfonic acid resin
- A61K47/585—Ion exchange resins, e.g. polystyrene sulfonic acid resin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
Landscapes
- Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Veterinary Medicine (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Medicinal Preparation (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Materials For Medical Uses (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
FI960435A FI960435A (fi) | 1996-01-30 | 1996-01-30 | Lääkkeiden transdermaalisen antotapaan tarkoitettu koostumus |
FI962450A FI962450A0 (fi) | 1996-06-12 | 1996-06-12 | Farmaceutisk sammansaettning och foerfarande foer dosering av laekemedel |
PCT/FI1997/000039 WO1997027844A1 (en) | 1996-01-30 | 1997-01-27 | Composition for transdermal delivery of drugs |
Publications (1)
Publication Number | Publication Date |
---|---|
ATE295157T1 true ATE295157T1 (de) | 2005-05-15 |
Family
ID=26160098
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
AT97901642T ATE295157T1 (de) | 1996-01-30 | 1997-01-27 | Mittel zur transdermalen verabreichung von arzneistoffen |
Country Status (7)
Country | Link |
---|---|
US (1) | US6254883B1 (de) |
EP (1) | EP0942716B1 (de) |
JP (1) | JP2000504002A (de) |
AT (1) | ATE295157T1 (de) |
CA (1) | CA2242753A1 (de) |
DE (1) | DE69733268T2 (de) |
WO (1) | WO1997027844A1 (de) |
Families Citing this family (12)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
FI107372B (fi) * | 1999-04-29 | 2001-07-31 | Novagent Oy | Laite vaikuttavan aineen annosteluun ja annostelun tutkimukseen |
EP1480527A4 (de) * | 2002-02-13 | 2005-03-30 | Beek Global Ninkov L L C Van | Zusammensetzungen und verfahren zur erhöhung der milchproduktion bei tieren |
WO2007078007A1 (ja) * | 2006-01-06 | 2007-07-12 | Japan Science And Technology Agency | カーボンナノホーン構造体並びにその内在有機物の放出を制御可能とする組成物とその方法 |
JP5558096B2 (ja) | 2007-03-01 | 2014-07-23 | 株式会社日本触媒 | 吸水性樹脂を主成分とする粒子状吸水剤 |
JP5879023B2 (ja) | 2007-04-05 | 2016-03-08 | 株式会社日本触媒 | 吸水性樹脂を主成分とする粒子状吸水剤 |
CN104722101A (zh) * | 2010-07-30 | 2015-06-24 | Emd密理博公司 | 层析介质和方法 |
FI125075B (fi) | 2012-08-13 | 2015-05-29 | Novagent Oy | Vaikuttavan aineen iontoforeettinen annostelujärjestelmä |
US20150374775A1 (en) * | 2013-04-10 | 2015-12-31 | Glycobiosciences Inc. | Topical nutraceutical composition |
US20210402050A1 (en) * | 2020-06-24 | 2021-12-30 | Anika Therapeutics, Inc. | Composite medical textile with non-resorbable fibers and bioresorbable hyaluronan-based fibers |
EP3188816B1 (de) | 2014-09-02 | 2021-06-09 | EMD Millipore Corporation | Chromatographie-medum, bestehend aus diskreten porösen bündeln von nanofibrillen |
BR112017007942A2 (pt) | 2014-10-30 | 2017-12-19 | Textile Based Delivery Inc | sistemas de liberação |
US20170298091A1 (en) | 2014-12-08 | 2017-10-19 | Emd Millipore Corporation | Mixed Bed Ion Exchange Adsorber |
Family Cites Families (15)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE603705C (de) | 1931-06-18 | 1934-10-08 | Desider Deutsch Dr | Elektrode zur Einfuehrung von Heilmitteln in den Koerper mittels Iontophorese |
FI52816C (fi) | 1974-03-28 | 1983-05-10 | Exel Oy | Trissa foer skidstav |
US4032452A (en) | 1975-11-13 | 1977-06-28 | Sybron Corporation | Electrically regenerated ion exchange system |
US4585652A (en) | 1984-11-19 | 1986-04-29 | Regents Of The University Of Minnesota | Electrochemical controlled release drug delivery system |
US4692462A (en) | 1985-03-18 | 1987-09-08 | Menley & James Laboratories, Ltd. | Compositions and method of controlling transdermal penetration of topical and systemic agents |
US4731049A (en) | 1987-01-30 | 1988-03-15 | Ionics, Incorporated | Cell for electrically controlled transdermal drug delivery |
US5080646A (en) | 1988-10-03 | 1992-01-14 | Alza Corporation | Membrane for electrotransport transdermal drug delivery |
US5162042A (en) | 1988-07-05 | 1992-11-10 | Alza Corporation | Electrotransport transdermal system |
US5098417A (en) * | 1990-04-12 | 1992-03-24 | Ricoh Kyosan, Inc. | Cellulosic wound dressing with an active agent ionically absorbed thereon |
US5147297A (en) | 1990-05-07 | 1992-09-15 | Alza Corporation | Iontophoretic delivery device |
ATE112496T1 (de) | 1991-03-11 | 1994-10-15 | Alza Corp | Iontophoretisches verabreichungssystem und verfahren zu seiner herstellung. |
WO1994008572A1 (en) | 1992-10-15 | 1994-04-28 | Alza Corporation | Delayed onset transdermal delivery device |
US5603955A (en) | 1994-07-18 | 1997-02-18 | University Of Cincinnati | Enhanced loading of solutes into polymer gels |
EP0739644A4 (de) | 1994-09-30 | 1998-12-09 | Advance Kk | Schnittstelle für eine transdermale iontophoretische vorrichtung und entsprechendes heilmittel |
WO1996010441A1 (en) | 1994-09-30 | 1996-04-11 | Becton Dickinson And Company | Iontophoretic drug delivery system, including disposable patch and reusable, removable controller |
-
1997
- 1997-01-27 DE DE69733268T patent/DE69733268T2/de not_active Expired - Lifetime
- 1997-01-27 CA CA002242753A patent/CA2242753A1/en not_active Abandoned
- 1997-01-27 AT AT97901642T patent/ATE295157T1/de not_active IP Right Cessation
- 1997-01-27 JP JP9527325A patent/JP2000504002A/ja active Pending
- 1997-01-27 WO PCT/FI1997/000039 patent/WO1997027844A1/en active IP Right Grant
- 1997-01-27 EP EP97901642A patent/EP0942716B1/de not_active Expired - Lifetime
- 1997-01-27 US US09/101,333 patent/US6254883B1/en not_active Expired - Lifetime
Also Published As
Publication number | Publication date |
---|---|
WO1997027844A1 (en) | 1997-08-07 |
EP0942716B1 (de) | 2005-05-11 |
US6254883B1 (en) | 2001-07-03 |
EP0942716A1 (de) | 1999-09-22 |
DE69733268D1 (de) | 2005-06-16 |
DE69733268T2 (de) | 2006-01-19 |
JP2000504002A (ja) | 2000-04-04 |
CA2242753A1 (en) | 1997-08-07 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
GT199900151A (es) | Sistema de entrega controlado de droga administrado oralmente, que provee control temporal y espacial. | |
EP0251680A3 (en) | Controlled release bioerodible drug delivery system | |
DE69506007D1 (de) | Transdermales system zur gleichzeitigen verabreichung von mehreren wirkstoffen | |
DE3650189D1 (de) | Mittel zur nichsystemischen Verabreichung von Sedativa und Analgetika. | |
PT693924E (pt) | Processos para administracao (in vivo) de substancias biologicas e composicoes utilizadas nestes processos | |
ES2007100A6 (es) | Procedimiento para la obtencion de un sistema terapeutico oral a base de carbamazepina. | |
NO920832D0 (no) | Faststoffmatrikssystem for transdermal medikamentavlevering | |
RU94032150A (ru) | Лекарственное средство с замедленным высвобождением активно-действующего вещества | |
DE3879853D1 (de) | Klebstoffzusammensetzung, zusammensetzung mit kontrollierter wirkstofffreisetzung und system zur transdermalen anwendung von arzneien. | |
ATE295157T1 (de) | Mittel zur transdermalen verabreichung von arzneistoffen | |
PT1003477E (pt) | Sistema terapeutico transdermico (tts), contendo polimeros de (met)acrilato com grupos amonio para administracao de levonorgestrel | |
ES2016620B3 (es) | Sistema para liberar medicamentos con bioaceptabilidad mejorada. | |
HUP9901890A2 (hu) | Gyógyszer és eljárás szervezet gyógyszeres kezelésére | |
TR200000149T2 (tr) | Serebral nörovasküler bozuklukların, müsküler baş ağrılarının önlenmesine yönelik kompozisyonlar | |
DE69922017D1 (de) | Arzneimittel und verfahren zur behandlung von intrazellulären infektionen | |
MY107420A (en) | Transdermal system exhibiting graduated drug release and its use for the local or systemic administration of active substances. | |
ATE208200T1 (de) | Transdermales therapeutisches system (tts) zur verabreichung von testosteron | |
DE59910944D1 (de) | Transdermales therapeutisches system zur anwendung von candesartan | |
AU3278800A (en) | Pharmaceutical composition containing desoxypeganine for the treatment of drug dependence | |
DE50010973D1 (de) | Pharmazeutische zusammensetzung, enthaltend desoxypeganin zur behandlung des alkoholismus | |
AU2503900A (en) | Sulfated phosphatidylinositols, their preparation and use | |
NO963143L (no) | Oral legemiddelform inneholdende colestipol som bærer med sure virkestoffer og fremgangsmåte ved fremstilling av denne | |
ATE234096T1 (de) | Pharmazeutische zusammensetzung zur systemischen transdermalen verabreichung mit dem wirkstoff morphin-6-glucuronid | |
DE60028207D1 (de) | Transdermales therapeutisches system zur verabreichung von calciumantagonisten | |
DE69727222D1 (de) | Zusammensetzung und system zur iontophoretischen transdermalen abgabe von medikamenten |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
RER | Ceased as to paragraph 5 lit. 3 law introducing patent treaties |